These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23152093)

  • 21. Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
    Pazianas M; Abrahamsen B; Wang Y; Russell RG
    Osteoporos Int; 2012 Dec; 23(12):2873-84. PubMed ID: 22431012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bisphosphonates and mortality: confounding in observational studies?
    Bergman J; Nordström A; Hommel A; Kivipelto M; Nordström P
    Osteoporos Int; 2019 Oct; 30(10):1973-1982. PubMed ID: 31367949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effect of early bisphosphonate treatment for pyogenic vertebral osteomyelitis with osteoporosis: An analysis by the Cox proportional hazard model.
    Kim J; Jang SB; Kim SW; Oh JK; Kim TH
    Spine J; 2019 Mar; 19(3):418-429. PubMed ID: 30172897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
    Modi A; Tang J; Sen S; Díez-Pérez A
    Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.
    Abelson A; Ringe JD; Gold DT; Lange JL; Thomas T
    Osteoporos Int; 2010 Jun; 21(6):1021-9. PubMed ID: 19722103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
    Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.
    Kumar A; Tsai WC; Tan TS; Chiu LT; Kung PT; Lo CK; Ku MC
    Clin Orthop Relat Res; 2016 Feb; 474(2):479-86. PubMed ID: 26566978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?
    Sapkota S; Baig S; Hess T; O'Connell AM; Menk J; Shyne M; Fazeli P; Ensrud K; Shmagel A
    Lupus; 2020 Mar; 29(3):263-272. PubMed ID: 31996109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of use of Chinese herbal medicines and the risk of fracture in patients with osteoporosis: a population-based cohort study.
    Chen WJ; Livneh H; Hsieh MH; Yeh CC; Yeh MH; Lu MC; Chien JT; Tsai TY
    Osteoporos Int; 2019 Apr; 30(4):807-815. PubMed ID: 30721331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of acute myocardial infarction after acute episode of schizophrenia: 6 year follow-up study.
    Lin HC; Chen YH; Lee HC; Lin HC
    Aust N Z J Psychiatry; 2010 Mar; 44(3):273-9. PubMed ID: 20050720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.
    Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS
    Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors.
    Cadarette SM; Solomon DH; Katz JN; Patrick AR; Brookhart MA
    Osteoporos Int; 2011 Mar; 22(3):943-54. PubMed ID: 20532481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonates Use and Risk of Subtrochanteric and Diaphyseal Femur Fractures in Korea: Results from the National Claim Registry.
    Lee YK; Byun DW; Jung SM; Kwon HY; Kim HY; Kim SH; Kim TY; Jang S; Ha YC
    Calcif Tissue Int; 2019 Mar; 104(3):313-319. PubMed ID: 30446771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Ha KY; Park KS; Kim SI; Kim YH
    Osteoporos Int; 2016 Feb; 27(2):483-8. PubMed ID: 26202489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.
    Davis S; Martyn-St James M; Sanderson J; Stevens J; Goka E; Rawdin A; Sadler S; Wong R; Campbell F; Stevenson M; Strong M; Selby P; Gittoes N
    Health Technol Assess; 2016 Oct; 20(78):1-406. PubMed ID: 27801641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Bisphosphonate Therapy With Incident of Lower Extremity Fractures in Persons With Spinal Cord Injuries or Disorders.
    Carbone LD; Gonzalez B; Miskevics S; Ray C; Etingen B; Guihan M; Craven BC; George V; Weaver FM
    Arch Phys Med Rehabil; 2020 Apr; 101(4):633-641. PubMed ID: 31958428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonate Use and the Risk of Undergoing Total Knee Arthroplasty in Osteoporotic Patients with Osteoarthritis: A Nationwide Cohort Study in Taiwan.
    Fu SH; Wang CY; Yang RS; Wu FL; Hsiao FY
    J Bone Joint Surg Am; 2017 Jun; 99(11):938-946. PubMed ID: 28590379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.
    Prieto-Alhambra D; Javaid MK; Judge A; Maskell J; Kiran A; Cooper C; Arden NK
    Osteoporos Int; 2011 May; 22(5):1555-71. PubMed ID: 20694456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation in fracture patients treated with oral bisphosphonates.
    Abrahamsen B; Eiken P; Brixen K
    J Intern Med; 2009 May; 265(5):581-92. PubMed ID: 19141097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.